GLAUKOS
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness. They have pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize the traditional glaucoma treatment and management paradigm. They launched the iStent®, their first MIGS device, in the United States in 2012. They are leverag... ing their platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. They believe the iStent® is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, they completed an initial public offering and their shares are now traded on the New York Stock Exchange under the ticker symbol “GKOS”. The company was founded in 1998 and is based in San Clemente, California.
GLAUKOS
Industry:
Health Care Medical Wellness
Founded:
1998-01-01
Address:
San Clemente, California, United States
Country:
United States
Website Url:
http://www.glaukos.com
Total Employee:
251+
Status:
Active
Contact:
19493679984
Email Addresses:
[email protected]
Total Funding:
121 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins Nginx
Similar Organizations
BetterNight
BetterNight is providing telehealth-based sleep solutions.
Big Health
Big Health is a digital therapeutics company operating a healthcare portal to offer behavioral programs for mental health issues.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
ComplexCare Solutions
ComplexCare Solutions is a health services company integrating care for complex, elderly, special needs, and dually-eligible individuals.
Minerva Surgical
Minerva Surgical is a medical device start-up company developing medical devices for women’s healthcare.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
UnitedHealth Group
UnitedHealth Group is a healthcare insurance company that offers health technology, health financial, and pharmacy services.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-11-21 | Avedro | Avedro acquired by Glaukos | N/A |
| 2019-06-19 | DOSE Medical Corp. | DOSE Medical Corp. acquired by Glaukos | 2.5 M USD |
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series F - Glaukos
Domain Associates
Domain Associates investment in Series F - Glaukos
Meritech Capital Partners
Meritech Capital Partners investment in Series F - Glaukos
OrbiMed
OrbiMed investment in Series F - Glaukos
InterWest Partners
InterWest Partners investment in Series F - Glaukos
Versant Ventures
Versant Ventures investment in Series F - Glaukos
Montreux Equity Partners
Montreux Equity Partners investment in Series F - Glaukos
OrbiMed
OrbiMed investment in Series E - Glaukos
Domain Associates
Domain Associates investment in Series E - Glaukos
Versant Ventures
Versant Ventures investment in Series E - Glaukos
Official Site Inspections
http://www.glaukos.com Semrush global rank: 1.91 M Semrush visits lastest month: 11.4 K
- Host name: 143.191.188.35.bc.googleusercontent.com
- IP address: 35.188.191.143
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Glaukos"
Advancing the Treatment of Ophthalmic Diseases
Glaukos is committed to investing in the future of ophthalmology to transform standards of care and improve patient lives. We’ve achieved many firsts in clinical studies and over the past several years, Glaukos has reinvested …See details»
Glaukos - Crunchbase Company Profile & Funding
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading …See details»
Glaukos Corporation - LinkedIn
Glaukos Corporation | 26,739 followers on LinkedIn. Pioneering new treatments for chronic eye diseases | At Glaukos, our focus is to develop and lead the global ophthalmic market with novel ...See details»
Glaukos - Investor Relations
Oct 16, 2024 Contact Us. Glaukos Corporation One Glaukos Way Aliso Viejo, CA 92656. 949-481-0510 Send Email Fax: 949-367-9984See details»
Governance & Sustainability - Executive Management - Glaukos
Contact Us. Glaukos Corporation One Glaukos Way Aliso Viejo, CA 92656. 949-481-0510 Send Email Fax: 949-367-9984See details»
Home | Glaukos
At Glaukos, we strive to continuously improve as responsible corporate citizens. We are dedicated to helping people in need, in our own community and beyond. We invest time and resources into better understanding what drives …See details»
Glaukos Corp - Overview, News & Similar companies - ZoomInfo
May 2, 2024 View Glaukos Corp (www.glaukos.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Glaukos Corporation (GKOS) Company Profile & Overview - Stock …
Jun 25, 2015 Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, …See details»
Glaukos Corporation (GKOS) - Yahoo Finance
The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is ...See details»
Glaukos - Investors - Governance & Sustainability - Corporate ...
Contact Us. Glaukos Corporation One Glaukos Way Aliso Viejo, CA 92656. 949-481-0510 Send Email Fax: 949-367-9984See details»
Governance & Sustainability - Board of Directors - Glaukos
Before joining Invitrogen, Mr. Hoffmeister spent 20 years with McKinsey & Company as a senior partner serving clients in the healthcare, private equity and chemical industries on issues of …See details»
Glaukos Announces Executive Leadership Changes - Business Wire
Feb 7, 2022 Under his leadership, Glaukos has successfully built a best-in-class commercial organization and significantly expanded its direct sales infrastructure into 17 countries. Mr.See details»
Our History | About Us - Glaukos
Glaukos.com: A Stripe cookie set for fraud prevention purposes and to help access the risk associated with an attempted transaction: 1 year: lpv: glaukos.com: A Pardot cookie set for …See details»
Glaukos Announces Executive Leadership Changes
Feb 7, 2022 Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal …See details»
Glaukos Charitable Foundation | About Us | Glaukos
The Glaukos Charitable Foundation is a philanthropic organization dedicated to helping the visually impaired and others in need. ... Glaukos has contributed more than 7,600 devices to …See details»
Glaukos Patient Services
Description of the glaukos. GPS Products Conditions. My Profile. Navigate your treatment journey with GPS Glaukos Patient Services (GPS) is an individualized support program for patients …See details»
Glaukos (GKOS) Earnings Date and Reports 2025 - MarketBeat
Nov 25, 2024 Glaukos posted Q3 2024 earnings on November 4, 2024, reporting an EPS of -$0.28, which topped analysts' consensus estimates of -$0.48 by $0.20. Quarterly revenue rose …See details»
Glaukos Announces the Release of its 2023 Sustainability Report
Apr 16, 2024 Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal …See details»
Our History - Glaukos
Glaukos.com: A Stripe cookie set for fraud prevention purposes and to help access the risk associated with an attempted transaction: 1 year: lpv: glaukos.com: A Pardot cookie set for …See details»
Glaukos - Glaukos to Support World Glaucoma Week with Patient …
Mar 8, 2021 Glaukos is pursuing FDA approval for additional MIGS surgical and sustained pharmaceutical therapy pipeline products, all of which are investigational in the United States. …See details»